JPS55133346A - Preparation of labeled peptide - Google Patents
Preparation of labeled peptideInfo
- Publication number
- JPS55133346A JPS55133346A JP3977879A JP3977879A JPS55133346A JP S55133346 A JPS55133346 A JP S55133346A JP 3977879 A JP3977879 A JP 3977879A JP 3977879 A JP3977879 A JP 3977879A JP S55133346 A JPS55133346 A JP S55133346A
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- labeled
- give
- compound
- residual group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
PURPOSE: To prepare a labeled peptide extremely useful for the investigation of in vivo metabolism and peptide hormone, economically and advantageously in an industrial scale, by labeling C-2 position of the tryptophan residual group in a peptide with potassium cyanide [13C or 14C], etc.
CONSTITUTION: A peptide I (A and B are amino acid, peptide residual group or their derivatives prepared by protecting their N or C ends with protective groups) is oxidized (e.g. ozone oxidation) to give the N-formylkynurenine derivative II. The compound II is reacted with an alkali metal cyanide labeled with 13C or 14C in a solvent to give the peptide having 2-aminoindolenine nucleus III (*mark exhibits the position labeled with 13C or 14C). The compound III is reacted with a hydride reagent (e.g. sodium borohydride, etc.) at 0W40°C under the condition of pH 7W 10 to give the compound IV having the tryptophan residual group labeled at C-2 position.
COPYRIGHT: (C)1980,JPO&Japio
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3977879A JPS55133346A (en) | 1979-04-04 | 1979-04-04 | Preparation of labeled peptide |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3977879A JPS55133346A (en) | 1979-04-04 | 1979-04-04 | Preparation of labeled peptide |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS55133346A true JPS55133346A (en) | 1980-10-17 |
JPS6227080B2 JPS6227080B2 (en) | 1987-06-12 |
Family
ID=12562386
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP3977879A Granted JPS55133346A (en) | 1979-04-04 | 1979-04-04 | Preparation of labeled peptide |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS55133346A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8980926B2 (en) | 2009-10-30 | 2015-03-17 | Genzyme Corporation | 2-aminoindole compounds and methods for the treatment of malaria |
-
1979
- 1979-04-04 JP JP3977879A patent/JPS55133346A/en active Granted
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8980926B2 (en) | 2009-10-30 | 2015-03-17 | Genzyme Corporation | 2-aminoindole compounds and methods for the treatment of malaria |
Also Published As
Publication number | Publication date |
---|---|
JPS6227080B2 (en) | 1987-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GR3018387T3 (en) | Fluorinated bile acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them. | |
ZA892474B (en) | Process for preparing derivatives of baccatine iii and of 10-deacetyl baccatine iii | |
TW248559B (en) | ||
ES8306137A1 (en) | Carboxylic acid derivatives, their preparation and use as pharmaceuticals. | |
JPS55133346A (en) | Preparation of labeled peptide | |
JPS5488241A (en) | Novel fortimicin a derivative | |
JPS5488242A (en) | Novel derivative of fortimicin b and its preparation | |
JPS52138527A (en) | Preparation of quinophthalones | |
GR70382B (en) | ||
IE802077L (en) | Nb-QUATERNARY DERIVATIVES OF AJMALINE AND ISOAJMALINE | |
JPS5337650A (en) | Preparation of 1,5-diphenoxyanthraquinone | |
JPS53103461A (en) | Preparation of purified alpha-nitro-beta-chloroantraquinoen | |
JPS55136281A (en) | Xanthine derivative | |
GB1491606A (en) | Process for the preparation of aliphatic beta-ketoesters | |
JPS57171989A (en) | Aminometyl-secalonic acid and its preparation | |
JPS57128665A (en) | 3-chloro-4-hydroxy-5-nitrophenylacetic acid amides and their preparation | |
JPS53127464A (en) | Preparation of indole derivatives | |
JPS5262291A (en) | Preparation of 7-aamino-deacetoxycephalosporanic acid derivatives | |
JPS5640679A (en) | Preparation of bisbenzofuranone derivative | |
JPS5268102A (en) | Preparation ofn-acylamino acid derivative solution | |
JPS549225A (en) | Preparation of hydrazinoalkanesulfonic acid derivatives | |
JPS53121785A (en) | Preparation of 7-tetrazolylacetamidocephalosporanic acid derivatives | |
ES476078A1 (en) | A procedure for preparing 1,3-thiazol-glioxylic acid derivatives. (Machine-translation by Google Translate, not legally binding) | |
JPS5363339A (en) | Synthesis of peptides | |
JPS6479196A (en) | Novel anthracycline derivative |